is semaglutide on fda shortage list deadline for compounded As of February 21, 2025, the updated its drug Ozempic and Wegovy officially moved

One of the most promising drug classes in recent years is GLP-1 receptor agonists, including semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro).These medications have revolutionized weight loss and diabetes management, with additional potential benefits in reducing risks for conditions like sleep apnea, cardiovascular disease, and even alcohol dependence

Talk with your doctor, share this article with friends considering therapy, and drop your questions or experiences in the comments below.

The logic is that GH-axis compounds are not dose-linear in a helpful way past a point: once the pulse is being driven hard, adding drug mostly buys more IGF-1 exposure, more fluid retention and more glucose disturbance rather than proportionally more benefit

GIP (Glucose-Dependent Insulinotropic Polypeptide) is another natural hormone that works alongside GLP-1